BTAI Buybacks
2 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–2; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| BioXcel Therapeutics, Inc. | 2020-12-31 | Reported repurchase cash | $0.00 |
| BioXcel Therapeutics, Inc. | 2020-03-31 | Reported repurchase cash | $9.02M |